Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01721434Phase 3Unknown
Phase 3, randomised, double-blind trial in diaphragm dysfunction and Weaning failure comparing Levosimendan with Placebo (2 arms). Primary endpoint: Neuro-mechanical efficiency of the diaphragm. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01721434.